Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula M Vertino

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Cancer Biology & Therapy|July 16, 2004
Epigenetic regulation of MDR1 gene in breast cancer: CpG methylation status dominates the stable maintenance of a silent geneDipali Sharma, Paula M Vertino
The Journal of Biological Chemistry|December 26, 2001
Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architectureKrista M Stimson, Paula M Vertino
Nature Genetics|June 1, 2002
Methylation matters: a new spin on maspinJoseph F Costello, Paula M Vertino
The Journal of Biological Chemistry|January 25, 2014
A dual role for the histone methyltransferase PR-SET7/SETD8 and histone H4 lysine 20 monomethylation in the local regulation of RNA polymerase II pausingPriya Kapoor-Vazirani, Paula M Vertino
Molecular Cell|April 3, 2012
R loops: lassoing DNA methylation at CpGiPaula M Vertino, Paul A Wade
Epigenomics|February 23, 2011
Molecular coupling of DNA methylation and histone methylationHideharu Hashimoto, Paula M Vertino, Xiaodong Cheng
Epigenetics|April 28, 2017
Orphan CpG islands define a novel class of highly active enhancersJoshua S K Bell, Paula M Vertino
Chinese Journal of Cancer|May 15, 2013
Dysregulation of mTOR activity through LKB1 inactivationWei Zhou, Adam I Marcus, Paula M Vertino
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Cancer DNA methylation: molecular mechanisms and clinical implicationsMichael T McCabe, Johann C Brandes, Paula M Vertino
Cancer Research|January 2, 2009
A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylationMichael T McCabe, Eva K Lee, Paula M Vertino
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Cancer Biology & Therapy|July 16, 2004
Epigenetic regulation of MDR1 gene in breast cancer: CpG methylation status dominates the stable maintenance of a silent geneDipali Sharma, Paula M Vertino
The Journal of Biological Chemistry|December 26, 2001
Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architectureKrista M Stimson, Paula M Vertino
Nature Genetics|June 1, 2002
Methylation matters: a new spin on maspinJoseph F Costello, Paula M Vertino
The Journal of Biological Chemistry|January 25, 2014
A dual role for the histone methyltransferase PR-SET7/SETD8 and histone H4 lysine 20 monomethylation in the local regulation of RNA polymerase II pausingPriya Kapoor-Vazirani, Paula M Vertino
Molecular Cell|April 3, 2012
R loops: lassoing DNA methylation at CpGiPaula M Vertino, Paul A Wade
Epigenomics|February 23, 2011
Molecular coupling of DNA methylation and histone methylationHideharu Hashimoto, Paula M Vertino, Xiaodong Cheng
Epigenetics|April 28, 2017
Orphan CpG islands define a novel class of highly active enhancersJoshua S K Bell, Paula M Vertino
Chinese Journal of Cancer|May 15, 2013
Dysregulation of mTOR activity through LKB1 inactivationWei Zhou, Adam I Marcus, Paula M Vertino
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Cancer DNA methylation: molecular mechanisms and clinical implicationsMichael T McCabe, Johann C Brandes, Paula M Vertino
Cancer Research|January 2, 2009
A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylationMichael T McCabe, Eva K Lee, Paula M Vertino
Pageof 8